Expression of α-, β- and γ-synuclein in colorectal cancer, and potential clinical significance in progression of the disease

Oncology Reports

Volumn 23, Issue 2, 2010, Pages 429-436

  Ye, Qing ^a,b,c   Wang, Ting Feng ^a,b,c   Peng, Yuan Fei ^a,b,c   Xie, Jing ^a   Feng, Bo ^a,b,c   Qiu, Ming Yuan ^a,b,c   Li, Liang Hui ^a,b,c   Lu, Ai Guo ^a,c   Liu, Bing Ya ^b   Zheng, Min Hua ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Digestive Surgery   (China)

^c Shanghai Minimally Invasive Surgery Center   (China)

Author keywords

Clinicopathological factors; Colorectal cancer; Expression; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-SYNUCLEIN; BETA-SYNUCLEIN; CACO-2 CELLS; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GAMMA-SYNUCLEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; LYMPHATIC METASTASIS; MATCHED-PAIR ANALYSIS; PROGNOSIS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 76649098026     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000652     Document Type: Article

References (30)

1. Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, Nussbaum RL and Polymeropoulos MH: Identification, localization and characterization of the human γ-synuclein gene. Human Genet 103: 106-112, 1998.
2. Lavedan C: The synuclein family. Genome Res 8: 871-880, 1998.
3. Clayton DF and George JM: The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21: 249-254, 1998.
4. Ahmad M, Attoub S, Singh MN, Martin FL and El-Agnaf OM: γ-synuclein and the progression of cancer. FASEB J 21: 3419-3430, 2007.
5. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y and Saitoh T: Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90: 11282-11286, 1993.
6. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R and Goedert M: Alpha-synuclein in Lewy bodies. Nature 388: 839-840, 1997.
7. Uversky VN, Li J, Souillac P, Millett IS, Doniach S, Jakes R, Goedert M and Fink AL: Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem 277: 11970-11978, 2002.
8. Park JY and Lansbury PT Jr: Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. Biochemistry 42: 3696-3700, 2003.
9. Ji H, Liu Y, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C and Shi YE: Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57: 759-764, 1997.
10. Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, Wang L, Zhao W, Jiang JD and Liu J: Loss of epigenetic control of synuclein-γ gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 65: 7635-7643, 2005.
11. Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L, Xie Y, Zhang J, Chen Y, Budman DR and Shi YE: Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer 121: 1296-1305, 2007.
12. Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao X, Chen Y, Budman D, Goldberg ID and Shi YE: Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Res Treat 101: 259-267, 2007.
13. Jia T, Liu YE, Liu J and Shi YE: Stimulation of breast cancer invasion and metastasis by synuclein-γ. Cancer Res 59: 742-747, 1999.
14. Gupta A, Inaba S, Wong OK, Fang G and Liu J: Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 22: 7593-7599, 2003.
15. Inaba S, Li C, Shi YE, Song DQ, Jiang JD and Liu J: Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 94: 25-35, 2005.
16. Pan ZZ, Bruening W, Giasson BI, Lee VM and Godwin AK: γ-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy rrug-induced apoptosis by modulating MAPK pathways. J Biol Chem 277: 35050-35060, 2002.
17. Fung KM, Rorke LB, Giasson B, Lee VM and Trojanowski JQ: Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas. Acta Neuropathol 106: 167-175, 2003.
18. Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ and Godwin AK: Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88: 2154-2163, 2000.
19. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 53: 43-66, 2007.
20. Gennari L, Russo A and Rossetti C: Colorectal cancer: what has changed in diagnosis and treatment over the last 50 years? Tumori 93: 235-241, 2007.
21. Samoha S and Arber N: Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side. Oncology 69: 33-37, 2005.
22. McGartland LP, Mulcahy MF and Benson III AB: Pre- and postoperative adjuvant therapy for locally advanced rectal cancer. Clin Adv Hematol Oncol 2: 806-814, 2004.
23. Ye Q, Zheng MH, Cai Q, Feng B, Chen XH, Yu BQ, Gao YB, Ji J, Lu AG, Li JW, Wang ML and Liu BY: Aberrant expression and demethylation of γ-synuclein in colorectal cancer, correlated with progression of the disease. Cancer Sci 99: 1924-1932, 2008.
24. Surgucheva IG, Sivak JM, Fini ME, Palazzo RE and Surguchov AP: Effect of γ-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 410: 167-176, 2003.
25. Pan ZZ, Bruening W and Godwin AK: Involvement of RHO GTPases and ERK in synuclein-γ enhanced cancer cell motility. Int J Oncol 29: 1201-1205, 2006.
26. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F and Cordon-Cardo C: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. Int J Oncol 24: 778-779, 2006.
27. Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D and Masliah E: Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res 914: 48-56, 2001.
28. Hashimoto M, Rockenstein E, Mante M, Mallory M and Masliah E: Beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 32: 213-223, 2001.
29. Windisch M, Hutter-Paier B, Rockenstein E, Hashimoto M, Mallory M and Masliah E: Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides. J Mol Neurosci 19: 63-69, 2002.
30. Da Costa CA, Masliah E and Checler F: Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease. J Biol Chem 278: 37330-37335, 2003.